Duan Yu-Hong, Liu Ai-Xia, Su Hong-Xia, Lv Ji-Hong, Gong Xue-Ying, Wang Li
Second Ward of Endocrinology Department, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
Medicine (Baltimore). 2020 Jun 5;99(23):e20366. doi: 10.1097/MD.0000000000020366.
Although previous studies have reported the effectiveness of acupuncture combined mecobalamin (AM) in the treatment of elderly diabetic peripheral neuropathy (EDPN), no systematic study has assessed its effectiveness and safety. Thus, this study will evaluate the effectiveness and safety of AM for the treatment of patients with EDPN.
Bibliographic electronic databases will be searched as follows: Cochrane Library, PUBMED, EMBASE, CINAHL, PsycINFO, WANGFANG, and China National Knowledge Infrastructure. All of them will be searched from each database initial to March 1, 2020 without language restrictions. All study selection, information extracted, and study quality evaluation will be performed by 2 independent authors. Any disagreements between 2 authors will be resolved by a third author via discussion. RevMan 5.3 software will be used for data pooling and meta-analysis performance if it is possible.
This study will provide synthesis of current evidence of AM for patients with EDPN through primary outcome of glycemic profile, and secondary of neuropathic pain intensity, plantar tactile sensitivity, sensory nerve conduction velocity and motor nerve conduction velocity, health-related quality of life, and adverse events.
This study will provide helpful reference for the efficacy and safety of AM for the treatment of patients with EDPN to the clinicians and further studies.Study registration number: INPLASY202040094.
尽管先前的研究报道了针刺联合甲钴胺(AM)治疗老年糖尿病周围神经病变(EDPN)的有效性,但尚无系统研究评估其有效性和安全性。因此,本研究将评估AM治疗EDPN患者的有效性和安全性。
将按以下方式检索文献电子数据库:Cochrane图书馆、PUBMED、EMBASE、CINAHL、PsycINFO、万方和中国知网。所有数据库均从建库初始至2020年3月1日进行检索,无语言限制。所有的研究筛选、信息提取和研究质量评估将由2名独立作者进行。两位作者之间的任何分歧将由第三位作者通过讨论解决。如有可能,将使用RevMan 5.3软件进行数据合并和荟萃分析。
本研究将通过血糖谱的主要结局以及神经病理性疼痛强度、足底触觉敏感性、感觉神经传导速度和运动神经传导速度、健康相关生活质量及不良事件的次要结局,综合目前关于AM治疗EDPN患者的证据。
本研究将为临床医生和进一步研究提供关于AM治疗EDPN患者有效性和安全性的有用参考。研究注册号:INPLASY202040094。